Minimal residual disease (MRD) testing is the future of diagnostics and monitoring for cancer, according to some experts. Not only can MRD determine the depth of response to a treatment, but it can also be used to determine treatment strategies.
Highlights
The global MRD Testing market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for MRD Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for MRD Testing is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for MRD Testing in Specialty Clinics and Hospitals is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of MRD Testing include ICON, ArcherDX, Arup Laboratories, ASURAGEN INC, Cergentis B.V., Bio-Rad Laboratories, Mission Bio, Guardant Health and Invivoscribe, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for MRD Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding MRD Testing.
The MRD Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global MRD Testing market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the MRD Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
ICON
ArcherDX
Arup Laboratories
ASURAGEN INC
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
Laboratory Corporation of America Holdings
Inivata Ltd
Natera, Inc
NeoGenomics Laboratories, Inc
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Adaptive Biotechnologies Corporation
Segment by Type
Flow Cytometry
Polymerase Chain Reaction (PCR)
Next-Generation Sequencing (NGS)
Other Technologies
Segment by Application
Specialty Clinics and Hospitals
Diagnostic Laboratories
Research Institutions
Other End Users
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of MRD Testing companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global MRD Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Flow Cytometry
1.2.3 Polymerase Chain Reaction (PCR)
1.2.4 Next-Generation Sequencing (NGS)
1.2.5 Other Technologies
1.3 Market by Application
1.3.1 Global MRD Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Specialty Clinics and Hospitals
1.3.3 Diagnostic Laboratories
1.3.4 Research Institutions
1.3.5 Other End Users
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global MRD Testing Market Perspective (2018-2029)
2.2 MRD Testing Growth Trends by Region
2.2.1 Global MRD Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 MRD Testing Historic Market Size by Region (2018-2023)
2.2.3 MRD Testing Forecasted Market Size by Region (2024-2029)
2.3 MRD Testing Market Dynamics
2.3.1 MRD Testing Industry Trends
2.3.2 MRD Testing Market Drivers
2.3.3 MRD Testing Market Challenges
2.3.4 MRD Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top MRD Testing Players by Revenue
3.1.1 Global Top MRD Testing Players by Revenue (2018-2023)
3.1.2 Global MRD Testing Revenue Market Share by Players (2018-2023)
3.2 Global MRD Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by MRD Testing Revenue
3.4 Global MRD Testing Market Concentration Ratio
3.4.1 Global MRD Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by MRD Testing Revenue in 2022
3.5 MRD Testing Key Players Head office and Area Served
3.6 Key Players MRD Testing Product Solution and Service
3.7 Date of Enter into MRD Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 MRD Testing Breakdown Data by Type
4.1 Global MRD Testing Historic Market Size by Type (2018-2023)
4.2 Global MRD Testing Forecasted Market Size by Type (2024-2029)
5 MRD Testing Breakdown Data by Application
5.1 Global MRD Testing Historic Market Size by Application (2018-2023)
5.2 Global MRD Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America MRD Testing Market Size (2018-2029)
6.2 North America MRD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America MRD Testing Market Size by Country (2018-2023)
6.4 North America MRD Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe MRD Testing Market Size (2018-2029)
7.2 Europe MRD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe MRD Testing Market Size by Country (2018-2023)
7.4 Europe MRD Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific MRD Testing Market Size (2018-2029)
8.2 Asia-Pacific MRD Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific MRD Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific MRD Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America MRD Testing Market Size (2018-2029)
9.2 Latin America MRD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America MRD Testing Market Size by Country (2018-2023)
9.4 Latin America MRD Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa MRD Testing Market Size (2018-2029)
10.2 Middle East & Africa MRD Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa MRD Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa MRD Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ICON
11.1.1 ICON Company Detail
11.1.2 ICON Business Overview
11.1.3 ICON MRD Testing Introduction
11.1.4 ICON Revenue in MRD Testing Business (2018-2023)
11.1.5 ICON Recent Development
11.2 ArcherDX
11.2.1 ArcherDX Company Detail
11.2.2 ArcherDX Business Overview
11.2.3 ArcherDX MRD Testing Introduction
11.2.4 ArcherDX Revenue in MRD Testing Business (2018-2023)
11.2.5 ArcherDX Recent Development
11.3 Arup Laboratories
11.3.1 Arup Laboratories Company Detail
11.3.2 Arup Laboratories Business Overview
11.3.3 Arup Laboratories MRD Testing Introduction
11.3.4 Arup Laboratories Revenue in MRD Testing Business (2018-2023)
11.3.5 Arup Laboratories Recent Development
11.4 ASURAGEN INC
11.4.1 ASURAGEN INC Company Detail
11.4.2 ASURAGEN INC Business Overview
11.4.3 ASURAGEN INC MRD Testing Introduction
11.4.4 ASURAGEN INC Revenue in MRD Testing Business (2018-2023)
11.4.5 ASURAGEN INC Recent Development
11.5 Cergentis B.V.
11.5.1 Cergentis B.V. Company Detail
11.5.2 Cergentis B.V. Business Overview
11.5.3 Cergentis B.V. MRD Testing Introduction
11.5.4 Cergentis B.V. Revenue in MRD Testing Business (2018-2023)
11.5.5 Cergentis B.V. Recent Development
11.6 Bio-Rad Laboratories
11.6.1 Bio-Rad Laboratories Company Detail
11.6.2 Bio-Rad Laboratories Business Overview
11.6.3 Bio-Rad Laboratories MRD Testing Introduction
11.6.4 Bio-Rad Laboratories Revenue in MRD Testing Business (2018-2023)
11.6.5 Bio-Rad Laboratories Recent Development
11.7 Mission Bio
11.7.1 Mission Bio Company Detail
11.7.2 Mission Bio Business Overview
11.7.3 Mission Bio MRD Testing Introduction
11.7.4 Mission Bio Revenue in MRD Testing Business (2018-2023)
11.7.5 Mission Bio Recent Development
11.8 Guardant Health
11.8.1 Guardant Health Company Detail
11.8.2 Guardant Health Business Overview
11.8.3 Guardant Health MRD Testing Introduction
11.8.4 Guardant Health Revenue in MRD Testing Business (2018-2023)
11.8.5 Guardant Health Recent Development
11.9 Invivoscribe
11.9.1 Invivoscribe Company Detail
11.9.2 Invivoscribe Business Overview
11.9.3 Invivoscribe MRD Testing Introduction
11.9.4 Invivoscribe Revenue in MRD Testing Business (2018-2023)
11.9.5 Invivoscribe Recent Development
11.10 Laboratory Corporation of America Holdings
11.10.1 Laboratory Corporation of America Holdings Company Detail
11.10.2 Laboratory Corporation of America Holdings Business Overview
11.10.3 Laboratory Corporation of America Holdings MRD Testing Introduction
11.10.4 Laboratory Corporation of America Holdings Revenue in MRD Testing Business (2018-2023)
11.10.5 Laboratory Corporation of America Holdings Recent Development
11.11 Inivata Ltd
11.11.1 Inivata Ltd Company Detail
11.11.2 Inivata Ltd Business Overview
11.11.3 Inivata Ltd MRD Testing Introduction
11.11.4 Inivata Ltd Revenue in MRD Testing Business (2018-2023)
11.11.5 Inivata Ltd Recent Development
11.12 Natera, Inc
11.12.1 Natera, Inc Company Detail
11.12.2 Natera, Inc Business Overview
11.12.3 Natera, Inc MRD Testing Introduction
11.12.4 Natera, Inc Revenue in MRD Testing Business (2018-2023)
11.12.5 Natera, Inc Recent Development
11.13 NeoGenomics Laboratories, Inc
11.13.1 NeoGenomics Laboratories, Inc Company Detail
11.13.2 NeoGenomics Laboratories, Inc Business Overview
11.13.3 NeoGenomics Laboratories, Inc MRD Testing Introduction
11.13.4 NeoGenomics Laboratories, Inc Revenue in MRD Testing Business (2018-2023)
11.13.5 NeoGenomics Laboratories, Inc Recent Development
11.14 Opko Health
11.14.1 Opko Health Company Detail
11.14.2 Opko Health Business Overview
11.14.3 Opko Health MRD Testing Introduction
11.14.4 Opko Health Revenue in MRD Testing Business (2018-2023)
11.14.5 Opko Health Recent Development
11.15 Quest Diagnostics Incorporated
11.15.1 Quest Diagnostics Incorporated Company Detail
11.15.2 Quest Diagnostics Incorporated Business Overview
11.15.3 Quest Diagnostics Incorporated MRD Testing Introduction
11.15.4 Quest Diagnostics Incorporated Revenue in MRD Testing Business (2018-2023)
11.15.5 Quest Diagnostics Incorporated Recent Development
11.16 Sysmex Corporation
11.16.1 Sysmex Corporation Company Detail
11.16.2 Sysmex Corporation Business Overview
11.16.3 Sysmex Corporation MRD Testing Introduction
11.16.4 Sysmex Corporation Revenue in MRD Testing Business (2018-2023)
11.16.5 Sysmex Corporation Recent Development
11.17 Adaptive Biotechnologies Corporation
11.17.1 Adaptive Biotechnologies Corporation Company Detail
11.17.2 Adaptive Biotechnologies Corporation Business Overview
11.17.3 Adaptive Biotechnologies Corporation MRD Testing Introduction
11.17.4 Adaptive Biotechnologies Corporation Revenue in MRD Testing Business (2018-2023)
11.17.5 Adaptive Biotechnologies Corporation Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
ICON
ArcherDX
Arup Laboratories
ASURAGEN INC
Cergentis B.V.
Bio-Rad Laboratories
Mission Bio
Guardant Health
Invivoscribe
Laboratory Corporation of America Holdings
Inivata Ltd
Natera, Inc
NeoGenomics Laboratories, Inc
Opko Health
Quest Diagnostics Incorporated
Sysmex Corporation
Adaptive Biotechnologies Corporation
听
听
*If Applicable.
